- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Gilead Sciences' top products based on revenue 2016-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Gilead Sciences' top products based on revenue 2016-2018
Top products of Gilead Sciences from 2016 to 2018, based on revenue (in million U.S. dollars)
This statistic shows the top products of biopharmaceutical company Gilead Sciences from 2016 to 2018, based on revenue. Gilead Sciences Inc. is headquartered in California and is specialized in discovering, developing and commercializing therapeutics. In 2018, Gilead Sciences' product Atripla generated some 1.2 billion U.S. dollars in revenue.
Top products of Gilead Sciences from 2016 to 2018, based on revenue (in million U.S. dollars)
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the top products of biopharmaceutical company Gilead Sciences from 2016 to 2018, based on revenue. Gilead Sciences Inc. is headquartered in California and is specialized in discovering, developing and commercializing therapeutics. In 2018, Gilead Sciences' product Atripla generated some 1.2 billion U.S. dollars in revenue.
Show more- Show sources information
- Show publisher information
- Release date
- February 2019
- Region
- Worldwide
- Survey time period
- 2016 to 2018
- Special properties
- Supplementary notes
- Data for 2013-2015 were taken from previous annual reports.
Source
- Show sources information
- Show publisher information
- Release date
- February 2019
More information
- Region
- Worldwide
- Survey time period
- 2016 to 2018
- Special properties
- Supplementary notes
- Data for 2013-2015 were taken from previous annual reports.
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Biotech industry
- 90 page/s
- English
- pptx
- Detailed references
Everything On "Biotech industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Biotech industry"
- Global overview
The most important statistics
- Global top 10 companies based on biotech prescription drug revenue in 2017 and 2024 (in billion U.S. dollars)*Global top companies based on biotech prescription drug revenue in 2017 and 2024
- Top global biotechnology companies based on market capitalization as of 2018 (in billion U.S. dollars)Top global biotech companies based on market capitalization 2018
- Select top global biotechnology companies' R&D expenditure in 2017 (in million U.S. dollars)Top global biotech companies - R&D expenditure 2017
- Selected top biotechnology companies based on number of employees worldwide in 2017Top global biotech companies based on number of employees 2017
- Value of the NASDAQ biotech Index from 2010 to 2017NASDAQ biotech index closing values 2010-2017
- Change in pharmaceutical and biotech industry stock indices worldwide in 2017Change in global biotech-pharma industry stock indices 2017
- U.S. companies
The most important statistics
- Gilead Sciences' revenue from 2006 to 2018 (in million U.S. dollars)Gilead Sciences' revenue 2006-2018
- Top products of Gilead Sciences from 2016 to 2018, based on revenue (in million U.S. dollars)Gilead Sciences' top products based on revenue 2016-2018
- Total revenue of biotech company Amgen from 2004 to 2018 (in million U.S. dollars)Amgen's total revenue 2004-2018
- Revenues of selected Amgen's top products from 2016 to 2018 (in million U.S. dollars)Amgen's top product revenues 2016-2018
- Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)Biogen's revenue and net income 2007-2018
- Biogen's top products from 2016 to 2018, based on revenue (in million U.S. dollars)Biogen's top products based on revenue 2016-2018
- Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016Market cap CAGR of biotech companies in the U.S. 2012-2016
- Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*Pre-commercial biotech companies with large market caps in the U.S. 2017
- Research & development
The most important statistics
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018
- Average cost to bring a pharmaceutical asset to market among large cap biopharma companies between 2010 and 2018 (in billion U.S. dollars)Cost to bring large cap biopharmaceutical assets to market 2010-2018
- Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018 (in billion U.S. dollars)Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2018
- Projected rate of return on biopharmaceutical research and development investments from 2010 to 2017Projected return on biopharma R&D investments U.S. 2010-2017
- Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (in million U.S. dollars)Alliances in U.S. and Europe biotechnology industry with big up-front payments 2016
- Products
The most important statistics
- Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)Global biologics spending 2002-2017
- Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)Top-selling biotech drugs based on revenue 2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*Pharmaceuticals: biopharma medicines in development 2018 by category
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Total U.S. pharmaceutical and biotech revenues for products 5 years after launch from 2007 to 2017 (in billion U.S. dollars)Total U.S. pharma and biotech product sales 5 years after launch 2007-2017
- Funding/investment
The most important statistics
- Total biotechnology funding by the National Institutes for Health (NIH) from FY 2013 to FY 2019 (in million U.S. dollars)biotechnology funding by National Institutes for Health 2013-2019
- Bioscience venture capital investments in the U.S. between 2014 and 2017, by sector (in million U.S. dollars)U.S. bioscience venture capital investments by segment 2014-2017
- Biotech/pharmaceutical investments in the legal cannabis industry in the United States from 2015 to 2017 (in million U.S. dollars)*Legal cannabis industry investments on biotech in the U.S. 2015-2017
- Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)Value of U.S. and EU biotech IPOs, January-October 2017
- Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars)Amount of top U.S. biotech venture financings 2017
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*Capital raised by regenerative medicine companies worldwide 2016-2018
- Biotech in agriculture
The most important statistics
- Acreage of genetically modified crops worldwide from 2003 to 2017 (in million hectares)Acreage of genetically modified crops worldwide 2003-2017
- Acreage of genetically modified crops worldwide from 2015 to 2017, by leading country (in million hectares)*Acreage of genetically modified crops 2015-2017, by country
- Percentage of genetically modified crops in the U.S. in 1997 and 2018, by type (as percent of total acreage)Percentage of genetically modified crops in the U.S. by type 2018
- Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*Monsanto's seed and genomics segment net sales 2011-2017
- Sales of Syngenta AG worldwide from 2013 to 2017, by segment (in billion U.S. dollars)Syngenta AG's sales worldwide by segment 2013-2017
- Bayer CropScience's revenue from 2005 to 2018 (in million euros)Bayer CropScience's revenue 2005-2018
Popular Related Keywords
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Top specialty drug pharmacies in the U.S. by revenue 2017
- Gilead Sciences' net income 2006-2018
- Top specialty drug pharmacies in the U.S. based on market share 2017
- Gilead Sciences' spending on research and development 2008-2018
- Definition of specialty drugs by PBMs and pharmacy executives 2011
- U.S. spending on biosimilars by type 2014
- Industry turnover for leading pharmaceuticals German 2016
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- Top global drugs based on revenue in Q2 2012
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- Volume of China's drug market 2007-2015
- Number of ANDA approvals in U.S. 2015-2017, by type
- Boehringer Ingelheim's expenditure on research and development 2004-2017
- Average number of approved ANDAs per month in U.S. 2009-2017
- U.S. spending on specialty medicine by type 2012-2016
- Top 20 branded drugs by retail dollars
- Deaths from drug poisoning due to psychostimulants abuse in U.S. 2005-2016
- Share of drug dispensing costs in select public drug plans Canada 2011-2017
- Top 20 branded drugs by retail dollars
- Global drug discovery market worldwide by segment 2016 and 2025
Studies
- Gilead Sciences - 2018 Form 10-K
- The Controversey over Rising Drug Prices: The Public's View
- Sobi Anual and sustainability report 2017
- Pharmaceutical industry in Italy
- Pharmaceutical trends in Europe
- Antibiotic use in the United Kingdom (UK)
- Teva - 2018 Form 10-K
- Biotechnology in Germany
- Overview of Korean Drug Research Association (KDRA), Korea Health Industry Development Ins...
- Celgene Corporation - 2018 Form 10-K
- Biogen Inc. - 2018 Form 10-K
- Boehringer Ingelheim - Annual Report 2017
- The 2018 Genentech Oncology Trend Report
- Indicatori Farmaceutici
- PAGB Annual Review 2017-2018
Statistics on "Biotech industry"
- Global top 10 companies based on biotech prescription drug revenue in 2017 and 2024 (in billion U.S. dollars)*
- Top global biotechnology companies based on market capitalization as of 2018 (in billion U.S. dollars)
- Select top global biotechnology companies' R&D expenditure in 2017 (in million U.S. dollars)
- Selected top biotechnology companies based on number of employees worldwide in 2017
- Value of the NASDAQ biotech Index from 2010 to 2017
- Change in pharmaceutical and biotech industry stock indices worldwide in 2017
- Gilead Sciences' revenue from 2006 to 2018 (in million U.S. dollars)
- Top products of Gilead Sciences from 2016 to 2018, based on revenue (in million U.S. dollars)
- Total revenue of biotech company Amgen from 2004 to 2018 (in million U.S. dollars)
- Revenues of selected Amgen's top products from 2016 to 2018 (in million U.S. dollars)
- Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)
- Biogen's top products from 2016 to 2018, based on revenue (in million U.S. dollars)
- Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016
- Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*
- Gross profit margin of selected U.S. biotech and drugs companies as of Q3 2018
- Expected top life science startups in the United States in 2019*
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*
- Average cost to bring a pharmaceutical asset to market among large cap biopharma companies between 2010 and 2018 (in billion U.S. dollars)
- Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018 (in billion U.S. dollars)
- Projected rate of return on biopharmaceutical research and development investments from 2010 to 2017
- Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (in million U.S. dollars)
- Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)
- Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
- Total U.S. pharmaceutical and biotech revenues for products 5 years after launch from 2007 to 2017 (in billion U.S. dollars)
- Total biotechnology funding by the National Institutes for Health (NIH) from FY 2013 to FY 2019 (in million U.S. dollars)
- Bioscience venture capital investments in the U.S. between 2014 and 2017, by sector (in million U.S. dollars)
- Biotech/pharmaceutical investments in the legal cannabis industry in the United States from 2015 to 2017 (in million U.S. dollars)*
- Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)
- Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars)
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*
- Acreage of genetically modified crops worldwide from 2003 to 2017 (in million hectares)
- Acreage of genetically modified crops worldwide from 2015 to 2017, by leading country (in million hectares)*
- Percentage of genetically modified crops in the U.S. in 1997 and 2018, by type (as percent of total acreage)
- Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*
- Sales of Syngenta AG worldwide from 2013 to 2017, by segment (in billion U.S. dollars)
- Bayer CropScience's revenue from 2005 to 2018 (in million euros)
- Top 10 pharmacies based on specialty drug revenue in the U.S. in 2017 (in billion U.S. dollars)
- Gilead Sciences' net income from 2006 to 2018 (in million U.S. dollars)
- Top specialty drug pharmacies in the United States based on market share in 2017
- Gilead Sciences' spending on research and development from 2008 to 2018 (in million U.S. dollars)
- Share of indications which define a specialty drug as of 2011*
- Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)*
- Industry turnover for leading pharmaceuticals in Germany in 2016 (in million euros)
- Expenditure on multiple sclerosis medicines in the United States from 2010 to 2014, by type (in billion U.S. dollars)
- Top global drugs based on revenue in Q2 2012 (in billion U.S. dollars)
- Spending growth on new brand specialty medicines in the United States in 2014 and 2015, by type (in billion U.S. dollars)
- China's drug market volume from 2007 to 2015 (in billion U.S. dollars)
- Number of abbreviated new drug applications (ANDAs) approvals in the U.S. from 2015 to 2017, by type of approval
- Boehringer Ingelheim's expenditure on research and development from 2004 to 2017 (in million euros)
- Average number of approved abbreviated new drug applications (ANDAs) per month in the U.S. from 2009 to 2017
- Expenditure on specialty medicines in the United States from 2012 to 2016, by type (in billion U.S. dollars)
- U.S. top 20 branded drugs by retail dollars in 2010 (in U.S. dollars)
- Number of deaths from psychostimulants poisoning from drugs with abuse potential in the U.S. from 2005 to 2016
- Dispensing costs as share of total Rx drug costs in select public drug plans in Canada from 2011/2012 to 2016/2017
- Top 20 branded drugs by retail dollars in the U.S. in 2009 (in 1,000 U.S. dollars)
- Drug discovery market worldwide by segment in 2016 and 2025 (in billion U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.